UPDATE: Another New York health official picked by US President Obama

19 May 2009

Following the selection by President Barack Obama of one former New York City Health Commissioner, Margaret Hamburg, to take over as  Commissioner of the US Food and Drug Administration (Marketletters  passim), the President has selected another holder of the same position,  Thomas Frieden, to be the next Director of the Atlanta,  Georgia-headquartered Centers for Disease Control and Prevention (CDC).

Dr Frieden's appointment is seen as a firm indicator of the new  administration's anti-smoking credentials. According to the New York  Times, when asked by a colleague after the September 11, 2001, terrorist  attacks what his priority as NY Health Commissioner would be in 2002, Dr  Frieden said: "Tobacco is killing more people, and that's my priority."

In addition to his New York public health activism, where he has pressed  for the banning of smoking and trans fats in restaurant, Dr Friedman  worked for five years in India on tuberculosis control.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight